Purespring Therapeutics Funding: $105M Raised, Series B
Purespring Therapeutics is a Biotech company based in London, United Kingdom. It has raised $105M in total funding. Latest round: Series B.
Purespring Therapeutics funding overview
Purespring Therapeutics is a Biotech company based in London, United Kingdom. Purespring Therapeutics has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2024. The round record for Purespring Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Sofinnova Partners, Gilde Healthcare, Forbion, British Patient Capital, Syncona. 5 distinct backers are named across the disclosed rounds.
Purespring Therapeutics at a glance
Total raised
$105M
Latest round
Series B
Latest round date
October 2024
Industry
Biotech
Headquarters
London, United Kingdom
Notable investors
Sofinnova Partners, Gilde Healthcare, Forbion, British Patient Capital, Syncona
Frequently asked about Purespring Therapeutics funding
How much has Purespring Therapeutics raised?
Purespring Therapeutics has raised $105M in total disclosed funding across the rounds on record.
Who has invested in Purespring Therapeutics?
Sofinnova Partners, Gilde Healthcare, Forbion, British Patient Capital, Syncona are named among the investors backing Purespring Therapeutics.
What was the latest Purespring Therapeutics funding round?
The most recent disclosed round is a Series B, announced in October 2024.
Where is Purespring Therapeutics based?
Purespring Therapeutics is based in London, United Kingdom.
What sector does Purespring Therapeutics operate in?
Purespring Therapeutics is tracked under Biotech from London, United Kingdom, with $105M in disclosed funding.
When did Purespring Therapeutics last raise?
The last disclosed Purespring Therapeutics round closed in October 2024 at Series B.
Purespring Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in London below to benchmark round size and investor mix.
